CA3056571C - N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives - Google Patents

N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives Download PDF

Info

Publication number
CA3056571C
CA3056571C CA3056571A CA3056571A CA3056571C CA 3056571 C CA3056571 C CA 3056571C CA 3056571 A CA3056571 A CA 3056571A CA 3056571 A CA3056571 A CA 3056571A CA 3056571 C CA3056571 C CA 3056571C
Authority
CA
Canada
Prior art keywords
compound
chloro
methoxypiperidin
thiadiazol
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3056571A
Other languages
English (en)
French (fr)
Other versions
CA3056571A1 (en
Inventor
Manoj Kumar Khera
Naresh Chintaman Dumbre
Pasha Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of CA3056571A1 publication Critical patent/CA3056571A1/en
Application granted granted Critical
Publication of CA3056571C publication Critical patent/CA3056571C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3056571A 2017-03-14 2018-03-13 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives Active CA3056571C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201711008754 2017-03-14
IN201711008754 2017-03-14
PCT/JP2018/010670 WO2018169092A1 (en) 2017-03-14 2018-03-13 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives

Publications (2)

Publication Number Publication Date
CA3056571A1 CA3056571A1 (en) 2018-09-20
CA3056571C true CA3056571C (en) 2021-11-23

Family

ID=62002340

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3056571A Active CA3056571C (en) 2017-03-14 2018-03-13 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives

Country Status (6)

Country Link
US (1) US10752647B2 (cg-RX-API-DMAC7.html)
EP (1) EP3596071A1 (cg-RX-API-DMAC7.html)
JP (1) JP2020511457A (cg-RX-API-DMAC7.html)
CA (1) CA3056571C (cg-RX-API-DMAC7.html)
TW (1) TW201840322A (cg-RX-API-DMAC7.html)
WO (1) WO2018169092A1 (cg-RX-API-DMAC7.html)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
ES2430569T3 (es) 2005-02-18 2013-11-21 Astrazeneca Ab Compuestos antibacterianos derivados de piperidina
EP1856103A2 (en) 2005-02-18 2007-11-21 AstraZeneca AB Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006087548A2 (en) 2005-02-18 2006-08-24 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
US20080269214A1 (en) 2005-03-04 2008-10-30 Astrazeneca Ab Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
JP2008531673A (ja) 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 抗菌活性をもつアゼチジン及びピロールの三環式誘導体
BRPI0620196A2 (pt) 2005-12-23 2013-01-15 Astrazeneca Ab composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente
TW200819437A (en) 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008020229A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020227A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200906412A (en) 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
EP2326640A1 (en) 2008-07-30 2011-06-01 Ranbaxy Laboratories Limited Pyrrole carboxylic acid derivatives as antibacterial agents
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
JP2011026305A (ja) * 2009-06-24 2011-02-10 Daiichi Sankyo Co Ltd イミダゾールカルボニル化合物を含有する医薬組成物
EP2616470B1 (en) * 2010-09-13 2016-10-12 Advinus Therapeutics Limited Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications
CA2887375C (en) 2012-10-10 2022-07-05 Vitas Pharma Research Pvt Ltd Inhibitors of dna gyrase for the treatment of bacterial infections
ES2817749T3 (es) 2015-09-30 2021-04-08 Daiichi Sankyo Co Ltd Derivados de hidroxialquil tiadiazol

Also Published As

Publication number Publication date
WO2018169092A1 (en) 2018-09-20
JP2020511457A (ja) 2020-04-16
US20200040019A1 (en) 2020-02-06
CA3056571A1 (en) 2018-09-20
US10752647B2 (en) 2020-08-25
TW201840322A (zh) 2018-11-16
EP3596071A1 (en) 2020-01-22

Similar Documents

Publication Publication Date Title
JP2903292B2 (ja) 抗菌性医薬
AU2016330271B2 (en) Hydroxyalkyl thiadiazole derivatives
EP0603887B1 (en) Bicyclic amine derivatives
RU2100351C1 (ru) Производные пиридонкарбоновой кислоты и композиция на их основе
EP2367820B1 (en) Novel antimicrobial agents
JP6671541B2 (ja) 抗菌剤として有用な複素環式化合物及びその生成方法
CN113845536A (zh) 含硼小分子
JP7473204B2 (ja) オキサゾリジノン抗生物質化合物及び調製方法
US10752647B2 (en) N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
EP0393923A1 (en) 6-Fluoroshikimic acid derivatives
EP0488227B1 (en) Optically active pyridobenzoxazine derivatives
CZ211394A3 (en) DERIVATIVES OF PYRIDO/1,2,3-d,e//1,3,4/BENZOXADIAZINE, PROCESS OF THEIR PREPARATION, USE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
JP2020511457A5 (cg-RX-API-DMAC7.html)
JP3771620B2 (ja) ヘテロ環式スピロ誘導体
HK1252275B (en) Hydroxyalkyl thiadiazole derivatives
TW201309689A (zh) 含胺基之吡咯啶酮衍生物
CN104803911A (zh) 一类截短侧耳素化合物、其药物组合物、合成方法与用途
CN119923396A (zh) 芳香乙炔类衍生物及其制备方法和其医药上的用途
EP0816355A1 (en) Heterocyclic spiro derivatives

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190913

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250915

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251109

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251113